Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
about
The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studiesThe angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathyExpression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy.Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration.Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).Optic disc fluorescein leakage and intraocular pressure in primary open-angle glaucoma.VEGF antagonists.Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis)Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusions.Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathySerum VEGF and CFH in exudative age-related macular degenerationVEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.A systematic meta-analysis of genetic association studies for diabetic retinopathy.Wogonin influences vascular permeability via Wnt/β-catenin pathway.Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relationDifferential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina.MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cellsEarly trials of angiogenic factors have not targeted patients most at risk of ocular disease.The relationship of photoreceptor degeneration to retinal vascular development and loss in mutant rhodopsin transgenic and RCS rats.Isolation and characterization of goat retinal microvascular endothelial cells.An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.Signal Alteration in the Optic Nerve Head on 3D T2-weighted MRI: a Potential Neuroimaging Sign of Glaucomatous Optic Neuropathy.The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys.
P2860
Q26823178-87549A0A-FE28-47C5-A684-D09D2E644D54Q30845192-4A4811C5-4A36-4876-9424-9245E3308D13Q31774297-D1DFF8B7-6473-4475-B796-E1F0981605F7Q31918268-6AA5FDCC-EEF6-4F17-9E6D-6E73808BB623Q33834038-433E8C56-358A-4621-9574-CF30918F0A42Q33943213-84934A88-4B02-4BBD-B377-A1B05D02631FQ34022792-E075D606-82AD-4A29-9782-1564A9D8517DQ34266150-105A5064-3CB5-432B-8056-B1D162D27AC0Q34451927-62AD3103-07C7-4810-963F-15D27A415A12Q35027435-0AB5E0A9-016D-42DE-B5B5-8A1100C65333Q35097904-E0308BF1-94A6-416C-B370-AC0AFD1EB91CQ36662676-997F8633-BB4D-48D4-9899-BAA0C8F0C025Q36860915-9B5E3EC5-294F-466C-BCD4-AB1A312485F1Q36868343-0CB57EC0-3FDF-44AE-A10D-092B65EE6312Q37317459-CEEF33A2-EDC0-4589-A01C-4C8348D19063Q39077180-47524481-DA95-4227-9E9C-DF358F8054C7Q40937602-1F17905B-2C84-4815-AB31-4C6E64663FBCQ41836616-E8F1347C-E750-4B58-BACD-7EF6E5E5BD6FQ41899278-8DD3165F-F7E7-43D7-81F1-0EF23EEE057CQ42111999-F0B7E0F9-C5B5-4CC7-A0BF-09E8987C6C13Q42596502-D96EC06D-F1A0-4FA6-9EBC-C3C58484FC55Q43137838-E6106C22-B5E1-4324-B940-AD889E3F6E89Q46899921-751B85FF-1778-4D9C-8A5C-BB2B9F59329AQ47626593-187C3675-31A5-4DB6-8015-306AF42FFBC6Q53116651-E21A983C-B426-4E18-8553-631BA63DA6AA
P2860
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
@ast
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
@en
type
label
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
@ast
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
@en
prefLabel
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
@ast
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
@en
P2860
P356
P1476
Role of vascular permeability factor/vascular endothelial growth factor in eye disease.
@en
P2093
R O Schlingemann
V W van Hinsbergh
P2860
P304
P356
10.1136/BJO.81.6.501
P407
P577
1997-06-01T00:00:00Z